FLT3
The FMS-like tyrosine kinase-3 (FLT-3) shares structural homology with other members of the class III receptor tyrosine kinase (RTK) family, such as KIT and FMS, with all members playing important roles in the survival, proliferation and differentiation of hematopoietic cells. FLT-3 is expressed in primitive CD34+ hematopoietic cells, dendritic cells, B-cell progenitors and natural killer cells. It has a limited range of tissue expression compared with FL, suggesting that FLT-3 is the major determinant of specificity. Wild-type FLT-3 appears to transduce its signaling cascade principally via the phosphotidylinositol-3 kinase (PI3K) and Ras pathways, leading to activation of AKT (protein kinase B), signal transducer and activator of transcription-5 (STAT5), and extracellular-signal regulated kinase-1 and -2 (ERK1/2). A number of compounds that target mutant and wild-type FLT-3 have recently been developed and are now in clinical trials.
References
1.Markovic A, et al. Int J Biochem Cell Biol. 2005;37(6):1168–1172.
References
1.Markovic A, et al. Int J Biochem Cell Biol. 2005;37(6):1168–1172.
Tyrosine Kinase
FLT3
-
Tetrahydrocoptisine
catalog no : M17739
cas no: 7461-02-1
Tetrahydrocoptisine has effective effects in suppressing inflammation. Tetrahydrocoptisine possesses a protective effect on LPS-induced ALI through inhibiting of NF-κB signaling pathways, which may involve the inhibition of pulmonary inflammatory process. -
Maslinic acid
catalog no : M17510
cas no: 4373-41-5
Maslinic acid is a DNA polymerase B inhibitor. -
CGS 27023A
catalog no : M17341
cas no: 161314-82-5
CGS 27023A is a non-peptidic, potent, and orally active stromelysin inhibitor. -
Trovirdine
catalog no : M17324
cas no: 149488-17-5
Trovirdine is a thiourea non-nucleoside reverse transcriptase inhibitor. -
KIN1148
catalog no : M17293
cas no: 1428729-56-9
KIN1148 is a novel small-molecule adjuvant that acts through the RIG-I pathway and IRF-3 transcription factor to stimulate inN/Ate immunity and protection following viral infection.